土耳其社区获得性呼吸道感染背景下的抗菌药物耐药性国家数据:抗生素敏感性、地方与国际抗生素处方指南、药物可及性与临床结局之间的联系
本文综述土耳其抗菌药物耐药性(AMR)现状及应对举措,梳理国家AMR行动、抗生素使用与处方、社区获得性呼吸道感染(CA-RTI)关键病原体肺炎链球菌与流感嗜血杆菌的药敏数据可及性,并比较当地常用的国内外CA-RTI处方指南与本地抗生素可及性,同时纳入当地临床医生与临床微生物学家的观点。
要点
- 土耳其抗菌药物耐药水平高、抗生素消耗量高,2015年禁止非处方抗生素销售后总体消耗呈下降趋势。
- 土耳其已制定抗生素管理规划《2014—2017年合理用药国家行动计划》,优先推动社区合理抗生素处方并开展公众宣教。
- 当地指南制定若采用土耳其社区获得性感染分离株的最新监测数据并更标准化、更具包容性,可能提高指南对临床医生的适用性。
核心结论
- 土耳其抗菌药物耐药水平高、抗生素消耗量高,但2015年禁止非处方抗生素销售后总体消耗呈下降趋势。
- 仍需对医生开展抗生素使用最新进展的教育。
- 采用土耳其社区获得性感染分离株的最新监测数据、以更标准化且更具包容性的方式制定本地指南,可使指南对临床医生更相关,从而为更高水平的合理抗生素处方与更好依从性铺路,进而可能限制AMR发展并改善患者结局。
研究设计与样本
- 本文为综述,检索范围为土耳其国家AMR举措、抗生素使用与处方情况、药敏数据可及性(尤其针对CA-RTI关键病原体肺炎链球菌与流感嗜血杆菌)、当地常用于特定CA-RTI(社区获得性肺炎、急性中耳炎、急性细菌性鼻窦炎)的国内外抗生素处方指南以及本地抗生素可及性,并征求当地临床医生与当地临床微生物学家的观点。
主要发现
- 土耳其抗菌药物耐药水平高、抗生素消耗量高,2015年禁止非处方抗生素销售后总体消耗呈下降趋势。
- 土耳其临床医生对常见CA-RTI使用若干本国指南以及一系列国际指南。
- 若干正在进行的全球监测研究提供土耳其的抗生素敏感性数据。
- 仍需对医生开展抗生素使用最新进展的教育。
临床怎么用
- 土耳其已制定抗生素管理规划《2014—2017年合理用药国家行动计划》,优先推动社区合理抗生素处方。
- 土耳其已启动劝阻不适当抗生素使用的公众宣传活动。
- 2015年土耳其禁止非处方抗生素销售。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action. OBJECTIVES: To review AMR in Türkiye and initiatives addressing it. Identifying any areas where more information is required will provide a call to action to minimize any further rise in AMR within Türkiye and to improve patient outcomes. METHODS: National AMR initiatives, antibiotic use and prescribing, and availability of susceptibility data, particularly for the key community-acquired respiratory tract infection (CA-RTI) pathogens Streptococcus pneumoniae and Haemophilus influenzae, were identified. National and international antibiotic prescribing guidelines commonly used locally for specific CA-RTIs (community-acquired pneumonia, acute otitis media, acute bacterial rhinosinusitis) were also reviewed, plus local antibiotic availability. Insights from both a local clinician and local clinical microbiologist were sought to contextualize this information. CONCLUSIONS: Türkiye developed an antibiotic stewardship programme, The Rational Drug Use National Action Plan 2014-2017, prioritizing appropriate antibiotic prescription in the community. Public campaigns discouraging inappropriate antibiotic use were also initiated. Türkiye has a high level of antibiotic resistance and a high level of consumption, however, in 2015 over-the-counter antibiotic sales were prohibited, resulting in a declining trend in overall consumption. There is still a need for physician education on current developments in antibiotic use. Several ongoing global surveillance studies provide antibiotic susceptibility data in Türkiye. Clinicians in Türkiye use several country-specific guidelines for common CA-RTIs plus a range of international guidelines. A more standardized inclusive approach in developing local guidelines, using up-to-date surveillance data on isolates from community-acquired infections in Türkiye, could make guideline use more relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve patient outcome.
引用
- Torumkuney D, Aktas Z, Unal S, et al. Country data on AMR in Türkiye in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. J Antimicrob Chemother. 2022. PMID: 36065733. doi:10.1093/jac/dkac217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。